Children's Hospital Oakland, Hematology/Oncology

Hematology/Oncology Division at Children's Hospital & Research Center Oakland

Recent Faculty Publications (2012 - 2014)

Books:

  • Hastings CA, Torkildson JC, Agrawal AK. Handbook of Pediatric Hematology and Oncology: Children's Hospital and Research Center Oakland. Second ed. West Sussex, United Kingdom: John Wiley & Sons, Ltd.; 2012. http://www.amazon.com/Handbook-Pediatric-Hematology-Oncology-Childrens/dp/0470670886
  • Taher A, Vichinsky E, Musallam K, Cappellini MD, Viprakasit V. Guidelines for the Management of Non Tranfusion Dependent Thalassemia (NTDT). ed. Cyprus: Thalassemia International Federation; 2013. http://thalassemia.com/documents/NTDT-TIF-guidelines.pdf
  • Vichinsky E, Levine L, Bhatia S, Bojanowski J, Coates T, Foote D, Fung E, Harmatz P, Jeng M, Knudsen J, Lal A, Pakbaz Z, Schroepfer C, Singer ST, Sweeters N, Walters M, Wood J. Standards of Care Guidelines for Thalassemia. Oakland, California: Children's Hospital & Research Center Oakland; 2012. http://hemonc.cho.org/thalassemia/documents/SOCGuidelines2012.pdf
  • Vichinsky E, Levine L, Bhatia S, Bojanowski J, Coates T, Foote D, Fung E, Harmatz P, Jeng M, Knudsen J, Lal A, Pakbaz Z, Schroepfer C, Singer ST, Sweeters N, Walters M, Wood J. Standards of Care Guidelines for Thalassemia. Oakland, California: Children's Hospital & Research Center Oakland; 2014 (in process).

Edited Books:

  • Feusner J, Hastings C, Agrawal AK, eds. Supportive Care in Pediatric Oncology. 3rd ed. New York, NY: Springer; 2013 (in press).
  • Vichinsky EP, ed. Emerging Therapies Targeting the Pathophysiology of Sickle Cell Disease. Hematology/Oncology Cinics of North America 2014/03/05 ed. Philadelphia, PA: Elsevier, Inc.; 2014. http://www.sciencedirect.com/science/journal/08898588/28/2

Book Chapters:

  • Ataga K, Vichinsky E. Thrombotic complications in sickle cell disease. In: Marder VJ, Aird WC, Bennett JS, Schulman S, White GC, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Chapter 122, Sixth (November 2012) ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2012:p. 1445. http://books.google.com/books?id=_SVbYgEACAAJ&dq=9781608319060
  • DeBaun M, Vichinsky E. Acute pain management in adults with sickle cell disease. In: Basow DS, ed. UpToDate. Topic 7144 Version 9.0; May 1, 2012. Waltham, MA: UpToDate, Inc.; 2013. http://www.uptodate.com/contents/acute-pain-management-in-adults-with-sickle-cell-disease
  • Field J, Vichinsky E, DeBaun M. Overview of the management of sickle cell disease. In: Basow DS, ed. UpToDate. Topic 7114 Version 27.0; Feb. 21, 2013. Waltham, MD: UpToDate, Inc.; 2013. http://www.uptodate.com/contents/overview-of-the-management-of-sickle-cell-disease
  • Fung EB, Chung J. Nutrition in Children with Sickle Cell Disease and Thalassemia. In: Green FR, Kleinman RE, eds. Pediatric Nutrition Handbook. 7th ed. : American Academy of Pediatrics; 2014: .
  • Garcia JR, Walters MC. Hematopoietic Cell Transplantation for non-malignant disorders. In: Greer J, ed. Wintrobe's Clinical Hematology. Lippincott Williams & Wilkins; 2013 (in press).
  • Khurana M, Su W. The Acute Abdomen. In: Feusner J, Hastings C, eds. Supportive Care in Pediatric Oncology. 3rd ed. New York, NY: Springer; 2013 (in press).
  • Lo CY, Morris CR. Vasculopathy, Chronic Oxidative Stress and Endothelial Dysfunction in SCD. In: Acuña-Castroviejo D, Rusanova I, eds. Sickle Cell Disease: A New Vision for an Old Problem. Chapter 5; : Nova Science Publishers; 2013. https://www.novapublishers.com/catalog/product_info.php?products_id=41344
  • Marsh A, Matsunaga A. Neonatal Alloimmune Thrombocytopenia. In: Cabana MD, ed. The 5-Minute Pediatric Consult. 7th ed: Lippincott Williams & Wilkins; 2014 (in press).
  • Saunthararajah Y, Vichinsky EP. Sickle Cell Disease: Clinical Features and Management. In: Hoffman R, ed. Hematology: Basic Principles and Practice. Chapter 40, 6th ed. Philadelphia, PA: Saunders/Elsevier; 2013. http://uclibs.org/PID/62059
  • Vichinsky E. Overview of the clinical manifestations of sickle cell disease. In: Basow DS, ed. UpToDate. Topic 7119 Version 23.0; Nov. 16, 2012. Waltham, MA: UpToDate, Inc.; 2013. http://www.uptodate.com/contents/overview-of-the-clinical-manifestations-of-sickle-cell-disease
  • Vichinsky E. Pregnancy in women with sickle cell disease. In: Basow DS, ed. UpToDate. Topic 7139 Version 10.0; Dec. 13, 2012. Waltham, MA: UpToDate, Inc.; 2013. http://www.uptodate.com/contents/pregnancy-in-women-with-sickle-cell-disease
  • Vichinsky E. Sickle Cell Syndromes. In: Decision Support in Medicine. http://decisionsupportinmedicine.com; 2013 (in press).
  • Vichinsky E. Sickle Cell Trait. In: Basow DS, ed. UpToDate. Topic 7145 Version 14.0; March 26, 2013. www.UpToDate.com: UpToDate, Inc.; 2013. http://www.uptodate.com/contents/sickle-cell-trait
  • Vichinsky E. Variant Sickle Cell Syndromes. In: Basow DS, ed. UpToDate. Topic 7115 Version 6.0; March 7, 2012. Waltham, MA: UpToDate, Inc.; 2013. http://www.uptodate.com/contents/variant-sickle-cell-syndromes
  • Vichinsky E, Mahoney DH. Diagnosis of sickle cell syndromes. In: Basow DS, ed. UpToDate. Topic 7113 Version 10.0; July 24, 2012. Waltham, MA: UpToDate, Inc.; 2013. http://www.uptodate.com/contents/diagnosis-of-sickle-cell-syndromes
  • Walters MC. Hematopoietic cell transplantation for sickle cell disease. In: Forman SJ, Negris RS, Antin J, Applebaum FR, eds. Hematopoietic Cell Transplantation. Fifth ed. Malden, MA: Blackwell Science; 2014 (in press): .

Journal Articles:

  • Adam SS, Hoppe C. Potential role for statins in sickle cell disease. Pediatr Blood Cancer 2013;60 4:60;4 p.550-7. http://www.ncbi.nlm.nih.gov/pubmed/23281161
  • Afshar M, Golden C. Report of neuroblastoma in a set of monozygotic monochorionic twins. Pediatr Hematol Oncol 2013;30 4:285-7. http://www.ncbi.nlm.nih.gov/pubmed/23373760
  • Agrawal AK, Hsu E, Quirolo K, Neumayr LD, Flori HR. Red blood cell transfusion in pediatric patients with severe chronic anemia: how slow is necessary? Pediatr Blood Cancer 2012;58 3:466-8. http://www.ncbi.nlm.nih.gov/pubmed/21793178
  • Agrawal AK, Kammen BF, Guo H, Donthineni R. An unusual presentation of subcutaneous granuloma annulare in association with juvenile-onset diabetes: case report and literature review. Pediatr Dermatol 2012;29 2:202-5. http://www.ncbi.nlm.nih.gov/pubmed/22085091
  • Aguilar A, Saba JD. Truth and consequences of sphingosine-1-phosphate lyase. Adv Biol Regul 2012;52 1:17-30. http://www.ncbi.nlm.nih.gov/pubmed/21946005
  • Amstrong D, Neumayr L, Gold JI, Weiner MW, Rule RR, LeBeau P, Kesler K, McMahon L, Orringer EP, Harrington T, DeCastro LM, Kalinyak K, Kutlar A, Rutherford CJ, Johnson C, Bessman JD, Hussein A, Vichinsky EP. Biologic predictors of memory, attention, and executive function in neurologically asymptomatic adults with sickle cell anemia. 2013 (submitted).
  • Bae HT, Baldwin CT, Sebastiani P, Telen MJ, Ashley-Koch A, Garrett M, Hooper WC, Bean CJ, Debaun MR, Arking DE, Bhatnagar P, Casella JF, Keefer JR, Barron-Casella E, Gordeuk V, Kato GJ, Minniti C, Taylor J, Campbell A, Luchtman-Jones L, Hoppe C, Gladwin MT, Zhang Y, Steinberg MH. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. Blood 2012;120 9:1961-2. http://www.ncbi.nlm.nih.gov/pubmed/22936743
  • Ballas SK, Kesen MR, Goldberg MF, Lutty GA, Dampier C, Osunkwo I, Wang WC, Hoppe C, Hagar W, Darbari DS, Malik P. Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal 2012;2012:949535. http://www.ncbi.nlm.nih.gov/pubmed/22924029
  • Ballas SK, Kesen MR, Goldberg MF, Lutty GA, Dampier C, Osunkwo I, Wang WC, Hoppe C, Hagar W, Darbari DS, Malik P. Erratum to "Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management". ScientificWorldJournal 2013;2013:861251. http://www.ncbi.nlm.nih.gov/pubmed/23483854
  • Bloch EM, Herwaldt BL, Leiby DA, Shaieb A, Herron RM, Chervenak M, Reed W, Hunter R, Ryals R, Hagar W, Xayavong MV, Slemenda SB, Pieniazek NJ, Wilkins PP, Kjemtrup AM. The third described case of transfusion-transmitted Babesia duncani. Transfusion 2012;52 7:1517-22. http://www.ncbi.nlm.nih.gov/pubmed/22168221
  • Chen Q, Fabry ME, Rybicki AC, Suzuka SM, Balazs TC, Etzion Z, de Jong K, Akoto EK, Canterino JE, Kaul DK, Kuypers FA, Lefer D, Bouhassira EE, Hirsch RE. A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress. Blood Cells Mol Dis 2012;48 2:91-101. http://www.ncbi.nlm.nih.gov/pubmed/22260787
  • Chokkalingam AP, Metayer C, Scelo G, Chang JS, Schiffman J, Urayama KY, Ma X, Hansen HM, Feusner JH, Barcellos LF, Wiencke JK, Wiemels JL, Buffler PA. Fetal growth and body size genes and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control 2012;23 9:1577-85. http://www.ncbi.nlm.nih.gov/pubmed/22878902
  • Chu J, Guo H, Raphael R, Torkildson J, Vichinsky E, Garrett C, Hastings C. Disseminated juvenile xanthogranuloma culminating in bone marrow necrosis and dath. PBC 2013 (submitted).
  • Cooper TM, Franklin J, Gerbing RB, Alonzo TA, Hurwitz C, Raimondi SC, Hirsch B, Smith FO, Mathew P, Arceci RJ, Feusner J, Iannone R, Lavey RS, Meshinchi S, Gamis A. AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group. Cancer 2012;118 3:761-9. http://www.ncbi.nlm.nih.gov/pubmed/21766293
  • Cui J, Azimi M, Adekile AD, Al Awadhi H, Hoppe CC. Detection of anti-Lepore Hb P-Nilotic by multiplex ligation-dependent probe amplification. Hemoglobin 2012;36 3:276-82. http://www.ncbi.nlm.nih.gov/pubmed/22384950
  • Cui J, Azimi M, Baysdorfer C, Vichinsky EP, Hoppe CC. Application of multiplex ligation-dependent probe amplification to screen for beta-globin cluster deletions: detection of two novel deletions in a multi ethnic population. Hemoglobin 2013;37 3:241-56. http://www.ncbi.nlm.nih.gov/pubmed/23577918
  • Cui J, Baysdorfer C, Azimi M, Vichinsky EP, Hoppe CC. Identification of three novel Hb F variants: Hb F-Hayward [Ggamma1(NA1)Gly-->Asp, GGT>GAT], Hb F-Chori-I [AgammaT16(A13)Gly-->Asp, GGC>GAC] and Hb F-Chori-II [AgammaI29(B11)Gly-->Glu, GGA>GAA]. Hemoglobin 2012;36 3:305-9. http://www.ncbi.nlm.nih.gov/pubmed/22384921
  • DeBaun MR, Armstrong FD, McKinstry RC, Ware RE, Vichinsky E, Kirkham FJ. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood 2012;119 20:4587-96. http://www.ncbi.nlm.nih.gov/pubmed/22354000
  • Delgado EM, Cho CS, Gildengorin G, Leibovich SA, Morris CR. SPeAK Asthma: A study of pediatric adherence and knowledge of asthma. Acad Emerg Med 2013 (under review).
  • Doh I, Lee WC, Cho YH, Pisano AP, Kuypers FA. Deformation measurement of individual cells in large populations using a single-cell microchamber array chip. Appl Phys Lett 2012;100 17:173702-1737023. http://www.ncbi.nlm.nih.gov/pubmed/22586355
  • Douer D, Zickl LN, Schiffer CA, Appelbaum FR, Feusner JH, Shepherd L, Willman CL, Bloomfield CD, Paietta E, Gallagher RE, Park JH, Rowe JM, Wiernik PH, Tallman MS. All-trans retinoic acid and late relapses in acute promyelocytic leukemia: Very long-term follow-up of the North American Intergroup Study I0129. Leuk Res 2013. http://www.ncbi.nlm.nih.gov/pubmed/23528262
  • Dror DK, King JC, Durand DJ, Fung EB, Allen LH. Feto-maternal vitamin D status and infant whole-body bone mineral content in the first weeks of life. Eur J Clin Nutr 2012;66 9:1016-9. http://www.ncbi.nlm.nih.gov/pubmed/22781021
  • Dror DK, King JC, Fung EB, Van Loan MD, Gertz ER, Allen LH. Evidence of associations between feto-maternal vitamin D status, cord parathyroid hormone and bone-specific alkaline phosphatase, and newborn whole body bone mineral content. Nutrients 2012;4 2:68-77. http://www.ncbi.nlm.nih.gov/pubmed/22413062
  • Flanagan JM, Sheehan V, Linder H, Howard TA, Wang YD, Hoppe CC, Aygun B, Adams RJ, Neale GA, Ware RE. Genetic mapping and exome sequencing identify two mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood 2013. http://www.ncbi.nlm.nih.gov/pubmed/23422753
  • Fung EB, Gariepy CA, Sawyer AJ, Higa A, Vichinsky EP. The effect of whole body vibration therapy on bone density in patients with thalassemia: a pilot study. Am J Hematol 2012;87 10:E76-9. http://www.ncbi.nlm.nih.gov/pubmed/22886910
  • Fung EB, Kwiatkowski JL, Huang JN, Gildengorin G, King JC, Vichinsky EP. Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2013;98 4:960-71. http://www.ncbi.nlm.nih.gov/pubmed/23945720
  • Fung EB, Xu Y, Trachtenberg F, Odame I, Kwiatkowski JL, Neufeld EJ, Thompson AA, Boudreaux J, Quinn CT, Vichinsky EP, Thalassemia Clinical Research N. Inadequate dietary intake in patients with thalassemia. J Acad Nutr Diet 2012;112 7:980-90. http://www.ncbi.nlm.nih.gov/pubmed/22551675
  • Gallagher RE, Moser BK, Racevskis J, Poire X, Bloomfield CD, Carroll AJ, Ketterling RP, Roulston D, Schachter-Tokarz E, Zhou DC, Chen IM, Harvey R, Koval G, Sher DA, Feusner JH, Tallman MS, Larson RA, Powell BL, Appelbaum FR, Paietta E, Willman CL, Stock W. Treatment-influenced associations of PML-RARalpha mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia. Blood 2012;120 10:2098-108. http://www.ncbi.nlm.nih.gov/pubmed/22734072
  • Garcia JR, Pollard J, Thomson B. Minimal Residual Disease in Acute Leukemias: review of literature and introduction of “bridging therapy” prior to hematopoietic cell transplantation. 2013 (submitted).
  • Goldberg SL, Giardina PJ, Chirnomas D, Esposito J, Paley C, Vichinsky E. The palatability and tolerability of deferasirox taken with different beverages or foods. Pediatr Blood Cancer 2013;60 9:1507-12. http://www.ncbi.nlm.nih.gov/pubmed/23637051
  • Gomez E, Morris CR. Asthma Management in Sickle Cell Disease. Biomed Res Int 2013;2013:604140. http://www.ncbi.nlm.nih.gov/pubmed/24324967
  • Green NS, Ender KL, Pashankar F, Driscoll C, Giardina PJ, Mullen CA, Clark LN, Manwani D, Crotty J, Kisselev S, Neville KA, Hoppe C, Barral S. Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea. PLoS One 2013;8 2:e55709. http://www.ncbi.nlm.nih.gov/pubmed/23409025
  • Grigoriev Y, Lange J, Peterson SM, Takashima JR, Ritchey ML, Ko D, Feusner JH, Shamberger RC, Green DM, Breslow NE. Treatments and outcomes for end-stage renal disease following Wilms tumor. Pediatr Nephrol 2012;27 8:1325-33. http://www.ncbi.nlm.nih.gov/pubmed/22430485
  • Haines D, Martin M, Carson S, Oliveros O, Green S, Coates T, Eile J, Schilling L, Dinu B, Mendoza T, Gerstenberger E, Trachtenberg F, Vichinsky E, Thalassemia Clinical Research N. Pain in thalassaemia: the effects of age on pain frequency and severity. Br J Haematol 2013;160 5:680-7. http://www.ncbi.nlm.nih.gov/pubmed/23278768
  • Hoppe CC. Prenatal and newborn screening for hemoglobinopathies. Int J Lab Hematol 2013;35 3:297-305. http://www.ncbi.nlm.nih.gov/pubmed/23590658
  • Hung YH, Faux NG, Killilea DW, Yanjanin N, Firnkes S, Volitakis I, Ganio G, Walterfang M, Hastings C, Porter FD, Ory DS, Bush AI. Altered transition metal homeostasis in Niemann-Pick disease, type C1. Metallomics 2013. http://www.ncbi.nlm.nih.gov/pubmed/24343124
  • Jacobs JE. Invasive aspergillus Infections in Hospitalized Pediatric Oncology Patients. 2013 (submitted).
  • Johnson KJ, Williams KS, Ross JA, Krailo MD, Tomlinson GE, Malogolowkin MH, Feusner JH, Spector LG. Parental tobacco and alcohol use and risk of hepatoblastoma in offspring: a report from the children's oncology group. Cancer Epidemiol Biomarkers Prev 2013;22 10:1837-43. http://www.ncbi.nlm.nih.gov/pubmed/23950215
  • Kanathezhath B, Shenvi S, Johl A, Manmohan R, Bhandhal MK, Oh D, Zhou A, Kuypers FA, Walters MC, Ames BN, Suh J. Systemic and Hepatic Thiol Redox Dysregulation in Graft Versus Host Disease. Biology of blood and marrow transplantation: Journal of the American Society for Blood and Marrow Transplantation 2012;18 2:S359-S60. http://linkinghub.elsevier.com/retrieve/pii/S1083879111009748?showall=true
  • Karafin MS, Graminske S, Erickson P, Walters MC, Scott E, Carter S, Padmanabhan A. Evaluation of the Spectra Optia Apheresis System for Mononuclear Cell (MNC) Collection in Mobilized and Non-mobilized Health Donors: Results of a Multicenter Study. J Clin Apheresis 2014 (submitted).
  • Karski EE, Dvorak CC, Leung W, Miller W, Shaw PJ, Qayed M, Katsanis E, Feusner JH. Treatment of Hepatoblastoma With High-dose Chemotherapy and Stem Cell Rescue: The Pediatric Blood and Marrow Transplant Consortium Experience and Review of the Literature. J Pediatr Hematol Oncol 2014. http://www.ncbi.nlm.nih.gov/pubmed/24577552.
  • Klaassen RJ, Barrowman N, Merelles-Pulcini M, Vichinsky EP, Sweeters N, Kirby-Allen M, Neufeld EJ, Kwiatkowski JL, Wu J, Vickars L, Blanchette VS, Forgie M, Yamashita R, Wong-Rieger D, Young NL. Validation and reliability of a disease-specific quality of life measure (the TranQol) in adults and children with thalassaemia major. Br J Haematol 2014;164 3:431-7. http://www.ncbi.nlm.nih.gov/pubmed/24180641
  • Klings E, Machado R, Barst R, Morris CR, Mubarak K, Gordeuk V, Kato GJ, Ataga K, Gibbs JS, Castro O, Berman-Rosenzweig E, Sood N, Hsu L, Wilson KC, Telen M, DeCastro LM, Krishnamurti L, Steinberg MH, Badesch DB, Gladwin MT. Consensus-Based Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension of Sickle Cell Disease. Am J Respir Crit Care Med 2013 (under review).
  • Kutlar A, Ataga K, Reid M, Vichinsky EP, Neumayr L, Blair-Britt L, Labotka R, Glass J, Keefer JR, Wargin WA, Berenson R, Perrine SP. A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease. Am J Hematol 2012;87 11:1017-21. http://www.ncbi.nlm.nih.gov/pubmed/22887019
  • Kutlar A, Ataga KI, McMahon L, Howard J, Galacteros F, Hagar W, Vichinsky E, Cheung AT, Matsui N, Embury SH. A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease. Am J Hematol 2012;87 5:536-9. http://www.ncbi.nlm.nih.gov/pubmed/22488107
  • Kutny MA, Moser BK, Laumann K, Feusner JH, Gamis A, Gregory J, Larson RA, Powell BL, Stock W, Willman CL, Woods WG, Meshinchi S. FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer 2012;59 4:662-7. http://www.ncbi.nlm.nih.gov/pubmed/22378655
  • Kuypers FA, Marsh AM. Research in athletes with sickle cell trait: just do it. J Appl Physiol 2012;112 9:1433. http://www.ncbi.nlm.nih.gov/pubmed/22362400
  • Kuypers FA. Hemoglobin S Polymerization and Red Cell Membrane Changes. Hematol Oncol Clin North Am 2014;28 2:155-79. http://www.ncbi.nlm.nih.gov/pubmed/24589260.
  • Kwiatkowski J, Kim HY, Thompson A, Quinn C, Mueller B, Odame I, Giardina P, Vichinsky E, Boudreaux JM, Porter J, Coates T, Olivieri N, Neufeld E. Chelation Choices and Iron Burden Among Patients with Thalassemia in the 21st Century. 2013 (submitted).
  • Kwiatkowski JL, Kim HY, Thompson AA, Quinn CT, Mueller BU, Odame I, Giardina PJ, Vichinsky EP, Boudreaux JM, Cohen AR, Porter JB, Coates T, Olivieri NF, Neufeld EJ, Thalassemia Clinical Research N. Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort. Blood 2012;119 12:2746-53. http://www.ncbi.nlm.nih.gov/pubmed/22279056
  • Lal A, Porter J, Sweeters N, Ng V, Evans P, Neumayr L, Kurio G, Harmatz P, Vichinsky E. Combined chelation therapy with deferasirox and deferoxamine in thalassemia. Blood Cells Mol Dis 2013;50 2:99-104. http://www.ncbi.nlm.nih.gov/pubmed/23151373
  • Locatelli F, Kabbara N, Ruggeri A, Ghavamzadeh A, Roberts I, Li CK, Bernaudin F, Vermylen C, Dalle JH, Stein J, Wynn R, Cordonnier C, Pinto F, Angelucci E, Socie G, Gluckman E, Walters MC, Rocha V, Eurocord, European B, Marrow Transplantation g. Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood 2013;122 6:1072-8. http://www.ncbi.nlm.nih.gov/pubmed/23692854
  • Mackin RS, Insel P, Truran D, Vichinsky EP, Neumayr LD, Armstrong FD, Gold JI, Kesler K, Brewer J, Weiner MW, On behalf of the Neuropsychological D, Neuroimaging Adult Sickle Cell Anemia Study G. Neuroimaging abnormalities in adults with sickle cell anemia: Associations with cognition. Neurology 2014. http://www.ncbi.nlm.nih.gov/pubmed/24523480
  • Marsh A, Golden C, Hoppe C, Quirolo K, Vichinsky E. Renal medullary carcinoma in an adolescent with sickle cell anemia. Pediatr Blood Cancer 2014;61 3:567. http://www.ncbi.nlm.nih.gov/pubmed/24108577
  • Marsh AM, Lo L, Cohen RA, Feusner JH. Sorafenib and bevacizumab for recurrent metastatic hepatoblastoma: stable radiographic disease with decreased AFP. Pediatr Blood Cancer 2012;59 5:939-40. http://www.ncbi.nlm.nih.gov/pubmed/22492703
  • Mattsson N, Olsson M, Gustavsson MK, Kosicek M, Malnar M, Mansson JE, Blomqvist M, Gobom J, Andreasson U, Brinkmalm G, Vite C, Hecimovic S, Hastings C, Blennow K, Zetterberg H, Portelius E. Amyloid-beta metabolism in Niemann-Pick C disease models and patients. Metab Brain Dis 2012;27 4:573-85. http://www.ncbi.nlm.nih.gov/pubmed/22935999
  • Mietus-Snyder ML, Shigenaga MK, Suh JH, Shenvi SV, Lal A, McHugh T, Olson D, Lilienstein J, Krauss RM, Gildengoren G, McCann JC, Ames BN. A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial. FASEB J 2012;26 8:3515-27. http://www.ncbi.nlm.nih.gov/pubmed/22549511
  • Morris CR. Arginine and Asthma. In: Nestlé Nutrition Institute Workshop Series. Basel, Switzerland: Karger AG; 2013 (in press).
  • Morris CR, Kim HY, Wood J, Porter JB, Klings ES, Trachtenberg FL, Sweeters N, Olivieri NF, Kwiatkowski JL, Virzi L, Singer ST, Taher A, Neufeld EJ, Thompson AA, Sachdev V, Larkin S, Suh JH, Kuypers FA, Vichinsky EP, Thalassemia Clinical Research N. Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension. Haematologica 2013;98 9:1359-67. http://www.ncbi.nlm.nih.gov/pubmed/23585527
  • Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP. A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. Haematologica 2013;98 9:1375-82. http://www.ncbi.nlm.nih.gov/pubmed/23645695
  • Musallam KM, Rivella S, Vichinsky E, Rachmilewitz EA. Non-transfusion-dependent thalassemias. Haematologica 2013;98 6:833-44. http://www.ncbi.nlm.nih.gov/pubmed/23729725
  • Musselman JR, Georgieff MK, Ross JA, Tomlinson GE, Feusner J, Krailo M, Spector LG. Maternal pregnancy events and exposures and risk of hepatoblastoma: A Children's Oncology Group (COG) study. Cancer Epidemiol 2013. http://www.ncbi.nlm.nih.gov/pubmed/23312454
  • Nazarov I, Lee JW, Soupene E, Etemad S, Knapik D, Green W, Bashkirova E, Fang X, Matthay MA, Kuypers FA, Serikov VB. Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential. Stem Cells Transl Med 2012;1 5:359-72. http://www.ncbi.nlm.nih.gov/pubmed/23197815
  • Nouraie M, Barst R, Kato GJ, Gibbs JS, Sachdev V, Machado RF, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli E, Girgis RE, Morris CR, Rosenzweig EB, Badesch DB, Lanzkron S, Castro OL, Taylor JGt, Goldsmith JC, Gladwin MT, Gordeuk V, Walk_Phasst_Investigators. NT-pro BNP is a biomarker of both right and left cardiac function in patients with sickle cell disease: Insights from Walk-PHaSST. Blood 2013 (under review).
  • Nouraie M, Lee JS, Zhang Y, Kanias T, Zhao X, Xiong Z, Oriss TB, Zeng Q, Kato GJ, Gibbs JS, Hildesheim ME, Sachdev V, Barst RJ, Machado RF, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli E, Girgis RE, Morris CR, Rosenzweig EB, Badesch DB, Lanzkron S, Castro OL, Goldsmith JC, Gordeuk VR, Gladwin MT, Walk PI, Patients. The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe. Haematologica 2013;98 3:464-72. http://www.ncbi.nlm.nih.gov/pubmed/22983573
  • Oliveros O, Trachtenberg F, Haines D, Gerstenberger E, Martin M, Carson S, Green S, Calamaras D, Hess P, Yamashita R, Vichinsky E, Thalassemia Clinical Research N. Pain over time and its effects on life in thalassemia. Am J Hematol 2013;88 11:939-43. http://www.ncbi.nlm.nih.gov/pubmed/23918696
  • Orgel E, Zung L, Ji L, Finklestein J, Feusner J, Freyer DR. Early cardiac outcomes following contemporary treatment for childhood acute myeloid leukemia: a North American perspective. Pediatr Blood Cancer 2013;60 9:1528-33. http://www.ncbi.nlm.nih.gov/pubmed/23441080
  • Paulukonis S, Neumayr L, Vichinsky E, RUSH_Project. RuSH SCD Methodology Paper. 2013 (in process).
  • Perilongo G, Malogolowkin M, Feusner J. Hepatoblastoma clinical research: Lessons learned and future challenges. Pediatric Blood & Cancer 2012;59 5:818-21. http://dx.doi.org/10.1002/pbc.24217
  • Polgreen LE, Thomas W, Fung E, Viskochil D, Stevenson DA, Steinberger J, Orchard P, Whitley CB, Ensrud KE. Low Bone Mineral Content and Challenges in Interpretation of Dual-Energy X-Ray Absorptiometry in Children With Mucopolysaccharidosis Types I, II, and VI. J Clin Densitom 2014;17 1:200-6. http://www.ncbi.nlm.nih.gov/pubmed/23562131
  • Porter JB, Wood J, Olivieri N, Vichinsky EP, Taher A, Neufeld E, Giardina P, Thompson A, Moore B, Evans P, Kim HY, Macklin EA, Trachtenberg F. Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone. J Cardiovasc Magn Reson 2013;15 1:38. http://www.ncbi.nlm.nih.gov/pubmed/23688265
  • Pratini NR, Sweeters N, Vichinsky E, Neufeld JA. Treatment of Classic Pantothenate Kinase-Associated Neurodegeneration with Deferiprone and Intrathecal Baclofen. Am J Phys Med Rehabil 2013. http://www.ncbi.nlm.nih.gov/pubmed/23370589
  • Puumala SE, Ross JA, Feusner JH, Tomlinson GE, Malogolowkin MH, Krailo MD, Spector LG. Parental infertility, infertility treatment and hepatoblastoma: a report from the Children's Oncology Group. Hum Reprod 2012;27 6:1649-56. http://www.ncbi.nlm.nih.gov/pubmed/22473396
  • Rapkin L, Feusner J. High-dose acetaminophen with N-acetylcysteine resuce enhances the efficacy of cisplatin chemotherapy. 2013 (submitted).
  • Reid ME, Hipsky CH, Hue-Roye K, Hoppe C. Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease. Blood Cells Mol Dis 2013. http://www.ncbi.nlm.nih.gov/pubmed/24309423
  • Romero Z, Urbinati F, Geiger S, Cooper A, Wherley J, Kaufman M, Hollis R, Senadheera S, Ruiz de Assin R, Sahagian A, Gellis A, Wang X, Gjertson D, DeOliveira S, Kempert P, Shupie S, Abdel-Azim H, Walters MC, Meiselman H, Wenby R, Gruber T, Marder V, Coates T, Kohn D. Transduction of Human Bone Marrow CD34+ Cells by a Lentiviral Vector Carrying a Modified Human ?-Globin Gene for Sickle Cell Disease. 2013 (submitted).
  • Singer S, Kuypers F, Fineman J, Gildengorin G, Larkin S, Sweeters N, Rosenfeld H, Kurio G, Higa A, Jeng M, Huang J, Vichinsky E. Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy. Ann Hematol. 2014:1-10. doi: 10.1007/s00277-014-2037-9. http://link.springer.com/article/10.1007/s00277-014-2037-9.
  • Smith S, Witkowski A, Moghul A, Yoshinaga Y, Nefedov M, de Jong P, Feng D, Fong L, Tu Y, Hu Y, Young SG, Pham T, Cheung C, Katzman SM, Brand MD, Quinlan CL, Fens M, Kuypers F, Misquitta S, Griffey SM, Tran S, Gharib A, Knudsen J, Hannibal-Bach HK, Wang G, Larkin S, Thweatt J, Pasta S. Compromised mitochondrial fatty acid synthesis in transgenic mice results in defective protein lipoylation and energy disequilibrium. PLoS One 2012;7 10:e47196. http://www.ncbi.nlm.nih.gov/pubmed/23077570
  • Sohn EY, Kato R, Noetzli LJ, Gera A, Coates T, Harmatz P, Keens TG, Wood JC. Exercise performance in thalassemia major: Correlation with cardiac iron burden. Am J Hematol 2013;88 3:193-7. http://www.ncbi.nlm.nih.gov/pubmed/23339082
  • Soni S, Boulad F, Cowan MJ, Edwards S, Dahake J, Walters MC. Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with non-malignant disorders. 2014 (submitted).
  • Soupene E, Kuypers FA. Phosphatidylcholine formation by LPCAT1 is regulated by Ca(2+) and the redox status of the cell. BMC Biochem 2012;13:8. http://www.ncbi.nlm.nih.gov/pubmed/22676268
  • Soupene E, Rothschild J, Kuypers FA, Dean D. Eukaryotic protein recruitment into the Chlamydia inclusion: implications for survival and growth. PLoS One 2012;7 5:e36843. http://www.ncbi.nlm.nih.gov/pubmed/22590624
  • Stookey JD, Klein A, Hamer J, Chi C, Higa A, Ng V, Arieff A, Kuypers FA, Larkin S, Perrier E, Lang F. RBC deformability and amino acid concentrations after hypo-osmotic challenge may reflect chronic cell hydration status in healthy young men. Physiol Rep 2013;1 5:e00117. http://www.ncbi.nlm.nih.gov/pubmed/24303184
  • Suh J, Kanathezhath B, Shenvi S, Guo H, Zhou A, Tiwana A, Kuypers F, Ames B, Walters M. Thiol/Redox Metabolomic Profiling Implicates GSH Dysregulation in Early Experimental Graft versus Host Disease (GVHD). PLoS ONE 2014;9 (2):e88868. 2014. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0088868
  • Switzer WM, Shankar A, Trimble SR, Thompson AA, Giardina PJ, Cohen AR, Coates TD, Vichinsky E, Neufeld EJ, Boudreaux JM, Heneine W. Human T Cell Lymphotropic Virus Type 1 Infection Among U.S. Thalassemia Patients. AIDS Res Hum Retroviruses 2013. http://www.ncbi.nlm.nih.gov/pubmed/23409829
  • Taylor LEV, Stotts NA, Humphreys J, Treadwell MJ, Miaskowski C. A Biopsychosocial-Spiritual Model of Chronic Pain in Adults with Sickle Cell Disease. Pain Management Nursing 2013;14 4:287-301. http://www.sciencedirect.com/science/article/pii/S1524904211001299
  • Te Vruchte D, Speak AO, Wallom KL, Al Eisa N, Smith DA, Hendriksz CJ, Simmons L, Lachmann RH, Cousins A, Hartung R, Mengel E, Runz H, Beck M, Amraoui Y, Imrie J, Jacklin E, Riddick K, Yanjanin NM, Wassif CA, Rolfs A, Rimmele F, Wright N, Taylor C, Ramaswami U, Cox TM, Hastings C, Jiang X, Sidhu R, Ory DS, Arias B, Jeyakumar M, Sillence DJ, Wraith JE, Porter FD, Cortina-Borja M, Platt FM. Relative acidic compartment volume as a lysosomal storage disorder-associated biomarker. J Clin Invest 2014. http://www.ncbi.nlm.nih.gov/pubmed/24487591
  • Thompson AA, Kim HY, Singer ST, Vichinsky E, Eile J, Yamashita R, Giardina PJ, Olivieri N, Parmar N, Trachtenberg F, Neufeld EJ, Kwiatkowski JL, Thalassemia Clinical Research N. Pregnancy outcomes in women with thalassemia in North America and the United Kingdom. Am J Hematol 2013;88 9:771-3. http://www.ncbi.nlm.nih.gov/pubmed/23757266
  • Tolar J, Mehta PA, Walters MC. Hematopoietic cell transplantation for nonmalignant disorders. Biol Blood Marrow Transplant 2012;18 1 Suppl:S166-71. http://www.ncbi.nlm.nih.gov/pubmed/22226101
  • Trachtenberg F, Haines D, Oliveros O. Design and Implementation of a Study to Assess Pain in Thalassemia. 2013 (in process).
  • Trachtenberg FL, Mednick L, Kwiatkowski JL, Neufeld EJ, Haines D, Pakbaz Z, Thompson AA, Quinn CT, Grady R, Sobota A, Olivieri N, Horne R, Yamashita R, Thalassemia Clinical Research N. Beliefs about chelation among thalassemia patients. Health Qual Life Outcomes 2012;10:148. http://www.ncbi.nlm.nih.gov/pubmed/23216870
  • Treadwell MJ, Bell M, Leibovich SA, Barreda F, Marsh A, Gildengorin G, Morris CR. A Quality Improvement Initiative to Improve Emergency Department Care for Pediatric Patients with Sickle Cell Disease. J Clin Outcomes Manage 2014;21 2:62-70. http://www.hospitalphysician.com/pdf/jcom_feb14_pediatric.pdf
  • Treadwell MJ, Hassell K, Levine R, Keller S. Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-Me): Conceptual Model Based on Review of the Literature and Formative Research. Clin J Pain 2013. http://www.ncbi.nlm.nih.gov/pubmed/24300219
  • Trimble S, Reyes N, Thompson A, Giardina P, Cohen A, Coates T, Vichinsky E, Neufeld E, Boudreaux J, Miller C, Grant A. Viral Seroconversion Monitoring in Chronically Transfused Thalassemia Patients in the United States, 2004-2009. 2013 (in process).
  • Trobaugh-Lotrario AD, Chaiyachati BH, Meyers RL, Haberle B, Tomlinson GE, Katzenstein HM, Malogolowkin MH, von Schweinitz D, Krailo M, Feusner JH. Outcomes for patients with congenital hepatoblastoma. Pediatr Blood Cancer 2013;60 11:1817-25. http://www.ncbi.nlm.nih.gov/pubmed/23798361
  • Trobaugh-Lotrario AD, Venkatramani R, Feusner J. Hepatoblastoma in children with Beckwith-Wiedemann syndrome: Does it warrant different treatment?. J Pediatr Hematol Oncol 2014. http://www.ncbi.nlm.nih.gov/pubmed/24608075.
  • Trobaugh-Lotrario AD, Feusner JH. Relapsed hepatoblastoma. Pediatric Blood & Cancer 2012;59 5:813-7. http://dx.doi.org/10.1002/pbc.24218
  • Trobaugh-Lotrario AD, Hirschmann B, Feusner J, Tomlinson G. Congenital Hepatoblastoma. 2013 (in process).
  • Ubogy S, Olson K. The Trauma Symptom Checklist for Children and Misdiagnosis of PTSD in A Youth with Acute Lymphocytic Leukemia: A Brief Report. Journal of Child & Adolescent Trauma 2014:1-3. http://rd.springer.com/article/10.1007/s40653-014-0004-1
  • Vichinsky E. Advances in the treatment of alpha-thalassemia. In: Blood Rev. 2012/05/29 ed; 2012:S31-4. http://www.ncbi.nlm.nih.gov/pubmed/22631041
  • Vichinsky E. Emerging 'A' therapies in hemoglobinopathies: agonists, antagonists, antioxidants, and arginine. Hematology Am Soc Hematol Educ Program 2012;2012:271-5. http://www.ncbi.nlm.nih.gov/pubmed/23233591
  • Vichinsky E, Neumayr L, Neuropsych_Study. The Safety and Efficacy of Transfusion Compared with Standard Care for the Treatment of Neurologic Dysfunction in Adults with Sickle Cell Disease. 2013 (in process).
  • Vichinsky E, Neumayr L, Trimble S, Giardina PJ, Cohen AR, Coates T, Boudreaux J, Neufeld EJ, Kenney K, Grant A, Thompson AA, Investigators CDCT. Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention. Transfusion 2013. http://www.ncbi.nlm.nih.gov/pubmed/23889533
  • Vichinsky E, Torres M, Minniti CP, Barrette S, Habr D, Zhang Y, Files B, study CAi. Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: Two-year results including pharmacokinetics and concomitant hydroxyurea. Am J Hematol 2013;88 12:1068-73. http://www.ncbi.nlm.nih.gov/pubmed/23946212
  • Vichinsky Eea. Prevalence of medical complications in patients with symptomatic thalassemia syndromes: Baseline findings from the Thalassemia Longitudinal Cohort (TLC) study. 2013 (in process).
  • Vichinsky EP. Clinical manifestations of alpha-thalassemia. Cold Spring Harb Perspect Med 2013;3 5:a011742. http://www.ncbi.nlm.nih.gov/pubmed/23543077
  • Vichinsky EP. Clinical Manifestations of a-Thalassemia. Cold Spring Harb Perspect Med 2013;(3) 3; 10.1101/cshperspect.a011742. http://perspectivesmedicine.net/content/early/2013/03/28/cshperspect.a011742.full.pdf+html
  • Vichinsky EP. Emerging therapy in hemoglobinopathies: lessons from the past and optimism for the future. Hematol Oncol Clin North Am 2014;28 2:xiii-xviii. http://www.ncbi.nlm.nih.gov/pubmed/24589274.
  • Vichinsky EP. The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells. Immunohematology 2012;28 1:20-3. http://www.ncbi.nlm.nih.gov/pubmed/22646146
  • Wahl SK, Garcia A, Hagar W, Gildengorin G, Quirolo K, Vichinsky E. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions. Transfusion 2012;52 12:2671-6. http://www.ncbi.nlm.nih.gov/pubmed/22519830
  • Wahl SK, Gildengorin G, Feusner J. Weekend delay in initiation of chemotherapy for acute lymphoblastic leukemia: does it matter? J Pediatr Hematol Oncol 2012;34 1:e8-e11. http://www.ncbi.nlm.nih.gov/pubmed/22146528
  • Walter PB, Porter J, Evans P, Kwiatkowski JL, Neufeld EJ, Coates T, Giardina PJ, Grady RW, Vichinsky E, Olivieri N, Trachtenberg F, Alberti D, Fung E, Ames B, Higa A, Harmatz P, Network TCR. Increased leucocyte apoptosis in transfused beta-thalassaemia patients. Br J Haematol 2013;160 3:399-403. http://www.ncbi.nlm.nih.gov/pubmed/23216540
  • Yamashita R, Sobota A, Trachtenberg F, Xu Y, Pakbaz Z, Odame I, Thompson A, Haines D, Kleinert D, Giardina P, Quinn C, Kwiatkowski J, Schilling L, Boudreaux J, Neufeld E. The impact of the child with thalassemia on the family: parental assessments 2013 (in process).

Editorials:


Letters:


Abstracts:

  • Adams-Graves P, Heeney M, Mueller B, Baltz B, Yang E, Paley C, Esposito J, McNamara K, Vichinsky E. Treatment patterns and clinical outcomes among patients with sickle cell disease: 24-month follow-up on a 3-year, prospective, non-interventional registry. ASPHO 27th Annual Meeting. Chicago, IL; May 14-17, 2014. Pediatric Blood & Cancer.
  • Aguilar A, Kumar A, Saba J. The effect of sphingadiene treatment on neuroblastoma cells. Sixth CHORI Research Symposium. Oakland, CA: Mar 30, 2012. Children's Hospital & Research Center Oakland.
  • Allard H, Weyhmiller MG, Lal A, Fung EB. In-accuracy of bone density measurements in patients with hemoglobinopathies and iron overload. 55th Annual Meeting of the American Society of Hematology. New Orleans, LA; Dec 7-10, 2013. Blood 122(966). http://bloodjournal.hematologylibrary.org/content/122/21/966.abstract?sid=c7ac5881-bd9e-4e29-9ad0-a192d4dd8428
  • Alter BP, Giri N, Calvo KR, Maric I, Arthur DC, Hickstein DD, Hastings CA, Lee MA, Hsu A, Holland SM. Clinically Silent Carriers in Families with Myelodysplastic Syndrome Due to GATA2 Mutations. 54th Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8-11, 2012. Blood 120(21); p.1264. http://abstracts.hematologylibrary.org/cgi/content/abstract/ashmtg;120/21/1264
  • Aydinok Y, Galanello R, Viprakasit V, Piga A, Harmatz P, Forni GL, Shah FT, Grace RF, Porter J, Vichinsky E, Wood J, Krishnan S, Zhang P, Abi-Saab W, Rienhoff HY, Neufeld E. The safety, tolerability and efficacy of FBS0701, an iron chelator in clinical development for transfusional iron overload: data from 72 weeks of treatment. 18th Congress of the European Hematology Association. Stockholm, Sweden: June 13-16, 2013. Haematologica.
  • Calloway C, Lee SH, Kim J, Dhillon N, Gildengorin G, Lal A. Mitochondrial Genome Changes As a Measure Of Iron-Induced Mitochondrial Stress In Transfusion-Dependent Thalassemia. 55th Annual Meeting of the American Society of Hematology. New Orleans, LA; Dec 7-10, 2013. Blood 122(21); 2256. http://bloodjournal.hematologylibrary.org/content/122/21/2256.abstract
  • Chung J, Feusner J. Utility of hematologic testing for cases of suspected non-accidental trauma. ASPHO 25th Annual Meeting. New Orleans, LA; May 9-12, 2012. Pediatric Blood & Cancer 58(7). http://www.connect2conferences.com/aspho4/ws_search/index.php?task=detail&abstract_id=806
  • Chung J, Fung EB, Feusner JH. A Pilot Study to Assess Alterations in Trace Element Status in Pediatric Patients with Malignancies. 54th Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8-11, 2012. Blood 120(21); p.3183. http://abstracts.hematologylibrary.org/cgi/content/abstract/ashmtg;120/21/3183
  • Chung J, Lal A, Vichinsky E. Increasing iron overload following splenectomy in Beta Thalassemia Major. ASPHO Annual Meeting. New Orleans, LA; May 9-12, 2012. Pediatric Blood & Cancer 58(7); p.1076. http://www.connect2conferences.com/aspho4/ws_search/index.php?task=detail&abstract_id=842
  • Fens MHAM, Larkin SK, Fitch WL, Scicinski J, Oronsky B, Kuypers FA. Treatment with a Novel Dinitroazetidine, Abdnaz, Improves Nitrite Reductase Activity of Sickle Red Blood Cells. 54th Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8-11, 2012. Blood 120(21); p.3246. http://abstracts.hematologylibrary.org/cgi/content/abstract/ashmtg;120/21/3246
  • Fung E. Low Magnitude Mechanical Stimulation Increases Bone Mass in Adult Patients with Thalassemia: A Pilot Study. Sixth CHORI Research Symposium. Oakland, CA: Mar 30, 2012. Children's Hospital & Research Center Oakland.
  • Fung EB, Kwiatkowski JL, Huang JN, Gildengorin G, King JC, Queisser AC, Vichinsky EP. Zinc supplementation improves bone density in young adults with thalassemia. 6th International Conference on Children's Bone Health; June 2013. Rotterdam, Netherlands.
  • Fung EB, Reget K, Sawyer A, Haines D, Lal A. Exploring vertebral abnormalities in patients with thalassemia and sickle cell disease. 6th International Conference on Children's Bone Health. Rotterdam, Netherlands; June 2013.
  • Gomez E, Calloway C, Hoon Lee S, Kim J, Dhillon N, Gildengoren G, Lal A. Mitochondrial genome changes as a measure of iron-induced mitochondrial stress in transfusion-depedent thalassemia. 55th Annual Meeting of the American Society of Hematology. New Orleans, LA; Dec 7-10, 2013. Blood 122(21); 2256. http://bloodjournal.hematologylibrary.org/content/122/21/2256.abstract
  • Galanello R, Aydinok Y, Piga A, Forni GL, Viprakasit V, Harmatz P, Shah F, Grace R, Vichinsky E, Wood J, Peppe J, Jones A, Rienhoff HY, Neufeld E. A 48 week phase 2 study of the safety, tolerability and efficacy of FBS0701, a novel iron chelator for treatment of transfusional iron overload. 17th Congress of the European Hematology Association. Amsterdam, The Netherlands: June 14-17, 2012. Haematologica 97(s1); #0606. http://www.ehaweb.org/congress-and-events/18th-congress/previous-congresses-2/abstract-book/eha-17-amsterdam-2012/
  • Hacker NA, King JC, Van Loan MD, Gertz ER, Adams M, Sawyer A, Fung EB. Calcium supplementation during pregnancy improves tibial bone density at one year post-partum in racially diverse women. Experimental Biology, April 2014. San Diego, CA. #14-7168.
  • Haines D. Pain in Thalassemia: Pervasive and Severe. 2nd Meeting of the Worldwide Initiative on Social Studies on Hemoglobinopathies. Atlanta, GA: March 16, 2012. poster presentation.
  • Heeney MM, Mueller BU, Baltz B, Adams-Graves P, Yang E, Paley C, Esposito J, Vichinsky EP. 12-Month Follow-up for Patients with Sickle Cell Disease in an Ongoing 3-Year, Prospective, Non-Interventional Registry Trial. 54th Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8-11, 2012. Blood 120(21); p.1010. http://abstracts.hematologylibrary.org/cgi/content/abstract/ashmtg;120/21/1010
  • Hoehner C, Hagar RW. A Dedicated Over 50 Sickle Cell Clinic. 6th Annual Sickle Cell Disease Research and Educational Symposium and Annual National Sickle Cell Scientific Meeting. Hollywood, Florida; Feb 29-Mar 2, 2012. Am J Hematol 87(7). http://onlinelibrary.wiley.com/doi/10.1002/ajh.23331/abstract
  • Jacobs J. Invasive Pulmonary Aspergillosis in Pediatric Oncology Patients. ASPHO 26th Annual Meeting. Miami, FL; April 24-27, 2013. Pediatric Blood & Cancer 60(S2). http://www.connect2conferences.com/aspho4/ws_search/index.php?task=detail&abstract_id=1243
  • Jubran RF, Leavey PJ, Ritchey AK, Tersak JM, Hastings C, Briones M, Shereck E, Nyquist J, Fisher D. Career development for pediatric hematology/oncology (PHO) fellows: a pilot program. ASPHO 26th Annual Meeting. Miami, FL; April 24-27, 2013. Pediatric Blood & Cancer 60(S2). http://www.connect2conferences.com/aspho4/ws_search/index.php?task=detail&abstract_id=1243
  • Kamani NR, Walters M, Carter S, Brochstein JA, Eapen M, Levine JE, Logan B, Panepinto J, Parikh S, Pulsipher M, Schultz KR, Shenoy S. Unrelated Donor Cord Blood Transplantation For Children With Severe Sickle Cell Disease: Results Of A Phase Ii Study From The Blood And Marrow Transplant Clinical Trials Network. BMT Tandem Meetings. San Diego, CA: Feb. 1-5, 2012. American Society for Blood and Marrow Transplantation #327. http://www.abstracts2view.com/bmt/view.php?nu=ASBMT12L_372
  • Kanathezhath B, Shenvi S, Johl A, Manmohan R, Bhandhal MK, Oh D, Zhou A, Kuypers FA, Walters MC, Ames BN, Suh J. Systemic And Hepatic Thiol Redox Dysregulation In Graft Versus Host Disease. BMT Tandem Meetings. San Diego, CA: Feb. 1-5, 2012. American Society for Blood and Marrow Transplantation #421. http://www.abstracts2view.com/bmt/view.php?nu=ASBMT12L_259
  • Kanathezhath B, Suh J, Shenvi S, Guo H, Walters M, Ames B. Glutathione Redox Metabolomic Dysregulation Precedes TNF-? Elevation and Predicts Severity of Gvhd in Experimental Transplantation. BMT Tandem Meetings. Salt Lake City, Utah: Feb. 13-17, 2013. American Society for Blood and Marrow Transplantation #438. https://bmt.confex.com/tandem/2013/webprogram/Paper2122.html
  • Khurana M, Feusner JH, Lee B. Fever at diagnosis of pediatric acute lymphoblastic leukemia (ALL): Are antibiotics really necessary. American Society of Clinical Oncology Annual Meeting. Chicago, Illinois; June 1-5, 2012. Abstract #9553. http://meetinglibrary.asco.org/content/101090-114
  • Klein O, Walters M, George D, Chu R, Goodrich JT, Roman E, Schubert R, Del Toro G. Moyamoya Syndrome Treated With Encephaloduroarteriosynangiosis Followed By Hematopoietic Cell Transplantation In Patients With Sickle Cell Disease. BMT Tandem Meetings. San Diego, CA: Feb. 1-5, 2012. American Society for Blood and Marrow Transplantation #276. http://www.abstracts2view.com/bmt/view.php?nu=ASBMT12L_344
  • Kutlar A, Reid M, Taher AT, Inati A, Abboud MR, El-Beshlawy A, Buchanan GR, Smith H, Ataga KI, Koshy N, Neumayr LD, Malik P, Alvarez OA, Ward R, White JM, Johnson E, Ghalie RG. A Randomized, Open-Label, Multicenter, Dose Escalation Study of HQK-1001 (2,2-Dimethylbutyrate, Sodium Salt) in Sickle Cell Disease. 54th Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8-11, 2012. Blood 120(21); p.998. http://abstracts.hematologylibrary.org/cgi/content/abstract/ashmtg;120/21/998
  • Lal A, Patterson L, Goldrich A, Marsh A, Yen K, Bhatnagar A. Detection of elevated end-tidal carbon monoxide concentration in children with sickle cell anemia. PAS/ASPR Joint Meeting. Vancouver, Canada: May3-6, 2014. Pediatric Academic Societies and Asian Society for Pediatric Research.
  • Lalefar N, Agarwal R, Porteus M, Kharbanda S, Weinberg K. Bortezomib As a Treatment for Autoimmune Cytopenia After Bone Marrow Transplant. BMT Tandem Meetings. Salt Lake City, Utah: Feb. 13-17, 2013. American Society for Blood and Marrow Transplantation #125.
  • Lalefar N, Ozeran J. Iron Overload in Childhood Cancer. ASPHO 25th Annual Meeting. New Orleans, LA; May 9-12, 2012. Pediatric Blood & Cancer 58(7). http://www.connect2conferences.com/aspho4/ws_search/index.php?task=detail&abstract_id=687
  • Latronica C, Kuypers FA, Rosenfeld H, Larkin SK, Doniger S, Vichinsky E, Morris CR. Tricuspid Regurgitant Jet Velocity (TRV), Biomarkers of Hemolysis, and Impact of Oxygen Therapy in Children with Sickle Cell Disease (SCD) and Vaso-Occlusive Pain Episodes (VOE). 54th Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8-11, 2012. Blood 120(21); p.4752. http://abstracts.hematologylibrary.org/cgi/content/abstract/ashmtg;120/21/4752
  • Latronica C, Kuypers FA, Rosenfeld H, Larkin SK, Doniger S, Vichinsky E, Shiva S. Citrate Synthase Activity Is Increased In Children With Sickle Cell Disease (SCD) On Hydroxyurea (HU) Therapy. 55th Annual Meeting of the American Society of Hematology. New Orleans, LA; Dec 7-10, 2013. Blood 122(21); 4690. http://bloodjournal.hematologylibrary.org/content/122/21/4690.abstract
  • Magnani JL, Kuypers FA, Patton JT, Larkin SK, Styles L, DeCastro LM, Telen MJ, Wun T, Thackray H. Pan-Selectin Antagonist GMI-1070 Affects Biomarkers of Adhesion, Activation and the Coagulation Cascade in Sickle Cell Adults At Steady State. 54th Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8-11, 2012. Blood 120(21); p.87. http://abstracts.hematologylibrary.org/cgi/content/abstract/ashmtg;120/21/87
  • Marsh A, Feusner J, Cham E. Are bone marrow core biopsies necessary for the initial diagnosis of acute leukemia? ASPHO 25th Annual Meeting. New Orleans, LA; May 9-12, 2012. Pediatric Blood & Cancer 58(7). http://www.connect2conferences.com/aspho4/ws_search/index.php?task=detail&abstract_id=783
  • Marsh AM, Quirolo KC, Golden C, Vichinsky E. Renal Medullary Carcinoma in an Adolescent with Homozygous Hemoglobin SS. 54th Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8-11, 2012. Blood 120(21); p.4774. http://abstracts.hematologylibrary.org/cgi/content/abstract/ashmtg;120/21/4774
  • Minor M, Harmatz P, Fuentebella J, Haines D, Lal A, Vichinsky E. Practical management of HCV genotype 1a in B thalassemia major with triple therapy. Viral Hepatitis Congress 2012. Frankfurt, Germany; Sep 7-9 2012. . Journal of Viral Hepatitis 19(s3); 10. <Go to ISI>://WOS:000308584500020
  • Morris CR, Barreda F, Leibovich SA, Rutherford M, Saulys A, Stewart M, Lavrisha L, Vichinsky E, Bell M, Treadwell MJ. Quality Improvement Goals for Sickle Cell Disease Pain Management in an Urban Pediatric Emergency Department: We Can Do Better! 54th Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8-11, 2012. Blood 120(21); p.2101. http://abstracts.hematologylibrary.org/cgi/content/abstract/ashmtg;120/21/2101
  • Morris CR, Barreda F, Leibovich SA, Rutherford M, Saulys A, Stewart M, Lavrisha L, Vichinsky E, Bell M, Treadwell MJ. Quality improvement initiatives for sickle cell disease pain management in an urban pediatric emergency department significantly improves outcomes. Pediatric Academic Societies Annual Meeting; May 4-7, 2013. Washington, DC. http://www.abstracts2view.com/pas/view.php?nu=PAS13L1_4523.443
  • Morris CR, Kim H-Y, Wood JC, Trachtenberg F, Klings ES, Porter JB, Sweeters N, Olivieri NF, Kwiatkowski JL, Singer ST, Taher AT, Neufeld EJ, Thompson AA, Larkin SK, Suh JH, Vichinsky E, Kuypers FA. Cardiopulmonary and Laboratory Profiling of Patients with Thalassemia At Risk for Pulmonary Hypertension: Report From the Thalassemia Clinical Research Network. 54th Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8-11, 2012. Blood 120(21); p.2122. http://abstracts.hematologylibrary.org/cgi/content/abstract/ashmtg;120/21/2122
  • Morris CR, Kim H-Y, Wood JC, Trachtenberg F, Klings ES, Porter JB, Sweeters N, Olivieri NF, Kwiatkowski JL, Singer ST, Taher AT, Neufeld EJ, Thompson AA, Sachdev V, Larkin SK, Suh JH, Kuypers FA, Vichinsky E. Sildenafil Therapy in Patients with Thalassemia and an Elevated Tricuspid Regurgitant Jet Velocity (TRV) On Doppler Echocardiography At Risk for Pulmonary Hypertension: Report From the Thalassemia Clinical Research Network. 54th Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8-11, 2012. Blood 120(21); p.1023. http://abstracts.hematologylibrary.org/cgi/content/abstract/ashmtg;120/21/1023
  • Morris HD, Feusner JH, Wilson KS, Aquino V, Levenson B, Timmons M, Cavalier M, Luu H. Therapy-induced t(11;19)(q23;q13.1) with relapsed acute promyelocytic leukemia. ASPHO 26th Annual Meeting. Miami, FL; April 24-27, 2013. Pediatric Blood & Cancer 60(S2); 895. http://www.connect2conferences.com/aspho4/ws_search/index.php?task=detail&abstract_id=895
  • Mueller BU, Baltz B, Adams-Graves P, Yang E, Paley C, MSHS JE, MSHS CCRA MK, Vichinsky E. Clinical Outcomes For Patients With Sickle Cell Disease: 24-Month Follow-Up In An Ongoing 3-Year, Prospective, Non-Interventional Registry Trial. 55th Annual Meeting of the American Society of Hematology. New Orleans, LA; Dec 7-10, 2013. Blood 122(21); 988. http://bloodjournal.hematologylibrary.org/content/122/21/988.abstract
  • Murray L, Walters MC, Chaudhury S, Soni S, Pulsipher MA, Schultz KR, Chan K, Nieder M, Loechelt B, Parikh SH, Kasow KA, Haight A, Hale GA, Connelly J, Andreansky M, Trachtenberg F, Neufeld EJ, Kwiatkowski J, DiFronzo NL, Thompson AA. Multicenter Investigation Of Unrelated Donor Hematopoietic Cell Transplantation (HCT) For Thalassemia Major After a Reduced Intensity Conditioning Regimen (URTH Trial). 55th Annual Meeting of the American Society of Hematology. New Orleans, LA; Dec 7-10, 2013. Blood 122(21); 543. http://bloodjournal.hematologylibrary.org/content/122/21/543.abstract
  • Porter J, Walter PB, Neumayr LD, Evans P, Weyhmiller MG, Harmatz P, Wood JC, Miller JL, Weiss G, Yuan Q, Wang ZJ, Grosse R, Schoennagel BP, Meerpohl J, Fischer R, Nielsen P, Seifert M, Vichinsky E. Inflammatory and Vitamin Bio-Markers Of Iron Trafficking and Distribution In Transfusional Overload: Insights From Comparing Diamond Blackfan Anemia With Sickle Cell Disease and Thalassemia (MCSIO PILOT Study). 55th Annual Meeting of the American Society of Hematology. New Orleans, LA; Dec 7-10, 2013. Blood 122(21); 1014. http://bloodjournal.hematologylibrary.org/content/122/21/1014.abstract
  • Porter JB, Walter PB, Neumayr LD, Evans P, Weyhmiller MG, Harmatz P, Wood JC, Miller JL, Weiss G, Yuan Q, Wang ZJ, Grosse R, Schoennagel BP, Meerpohl J, Fischer R, Seifert M, Vichinsky E. Bio-markers of Iron Trafficking and Distribution in Transfusional Overload: Insights from Comparing Diamond Blackfan Anemia with Sickle Cell Disease and Thalassemia (MCSIO Pilot Study). International BioIron Society Meeting. University College London; April 14-18, 2013.
  • Porter JB, Walter PB, Neumayr LD, Evans P, Weyhmiller MG, Harmatz P, Wood JC, Miller JL, Weiss G, Yuan Q, Wang ZJ, Grosse R, Schoennagel BP, Meerpohl J, Fischer R, Vichinsky E. Iron Trafficking and Distribution in Transfusional Overload: Insights From Comparing Diamond Blackfan Anemia with Sickle Cell Disease and Thalassemia. 54th Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8-11, 2012. Blood 120(21); p.995. http://abstracts.hematologylibrary.org/cgi/content/abstract/ashmtg;120/21/995
  • Radhakrishnan K, Talano J, Keever-Taylor C, Bhatia M, Shenoy S, Walters M, Parsons S, Morris E, Baxter-Lowe LA, Cairo MS. Familial Haploidentical (FHI) T-Cell Depleted (TCD) Transplantation In High-Risk Sickle Cell Disease (IND 14359). BMT Tandem Meetings. San Diego, CA: Feb. 1-5, 2012. American Society for Blood and Marrow Transplantation #265. http://www.abstracts2view.com/bmt/view.php?nu=ASBMT12L_203
  • Schiffelers R, Gildengorin G, Kuypers FA, Hoppe C. Microparticles As Biomarkers Of Osteonecrosis Of The Hip In Sickle Cell Disease. 55th Annual Meeting of the American Society of Hematology. New Orleans, LA; Dec 7-10, 2013. Blood 122(21); 2226. http://bloodjournal.hematologylibrary.org/content/122/21/2226.abstract
  • Suh JH, Kanathezhath B, Swapna S, Guo H, Walters MC, Ames BN. Host Nrf2 -glutathione Redox Dysregulation Precedes TNF-{alpha} Elevation and Predicts Severity of Graft Versus Host Disease in Experimental Transplantation. 54th Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8-11, 2012. Blood 120(21); p.4107. http://abstracts.hematologylibrary.org/cgi/content/abstract/ashmtg;120/21/4107
  • Treadwell MJ, Anie K, Asafo M, Creary M, Dennis-Atwi J, grant A, Lamptey M, Ojodu J, Otaigbe A, Yusuf C, Ohene-Frempong K. Development Workshop for a Sickle Cell Counselor Training and Certification Program in Ghana. SCDAA 41st Annual Convention; Sept 25-27, 2013. Baltimore, MD.
  • Treadwell MJ, Barreda F, Payton W, Sydnor V, Murphy W. Using Multidimensional Strategies to Improve Adherence with Iron Chelation Therapies. SCDAA 41st Annual Convention; Sept 25-27, 2013. Baltimore, MD.
  • Treadwell MJ, Bell M, Leibovich SA, Barreda F, Marsh A. Quality improvement initiative improves emergency department care for pediatric patients with sickle cell disease. UCSF Seventh Annual Health Disparities Research Symposium. Oct 23, 2013; San Francisco, CA.
  • Trobaugh-Lotrario AD, Chaiyachati BH, Meyers R, Haberle B, Tomlinson GE, Katzenstein HM, Malogolowkin MH, von Schweinitz D, Krailo MD, Feusner JH. Outcome in congenital hepatoblastoma compared with previously reported data. 2013 ASCO Annual Meeting. May 30 - Jun 3, 2014; Chicago, Illinois. American Society of Clinical Oncology. http://meetinglibrary.asco.org/content/118312-132
  • Vichinsky E. Fetal hemoglobin and its relationship to CNS disease in hemoglobinopathies. 18th Annual Hemoglobin Switching Conference. Monterey, California; June 7-11, 2012.
  • Vichinsky E, Beshlawy AE, Alzoebie A, Bernaudin F, Koussa S, Chotsampancharoen T, El-Ali A, Arrowsmith C, Martin M, El-Alfy M. Long-term safety and effectiveness of deferasirox (Exjade®) in pediatric patients aged 2–<6 years at enrollment: Interim report from a 5-year observational study. 3rd Pan-European Conference on Haemoglobinopathies and Rare Anaemias. Limassol, Cyprus: Oct 24-26, 2012.
  • Vichinsky E, El-Beshlawy A, Alzoebie A, Bernaudin F, Koussa S, Chotsampancharoen T, El-Ali A, Arrowsmith C, Martin N, El-Alfy M. Interim Safety and Effectiveness Results From a 5-Year Observational Study of Deferasirox in Pediatric Patients Aged 2-<6 Years At Enrollment. 54th Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8-11, 2012. Blood 120(21); p.2125. http://abstracts.hematologylibrary.org/cgi/content/abstract/ashmtg;120/21/2125
  • Walter PB, Harmatz P, Higa A, Ng V, Weyhmiller MG, Evans P, Porter JB, Sweeters N, Price J, Manji A, Killilea D, Lal A, Vichinsky E. Innate Immune Cell Expression of Pattern Recognition Receptors From {beta}-Thalassemia Patients During Intensive Combination Chelation Therapy. 54th Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8-11, 2012. Blood 120(21); p.1025. http://abstracts.hematologylibrary.org/cgi/content/abstract/ashmtg;120/21/1025
  • Walter PB, Harmatz P, Higa A, Ng V, Weyhmiller MG, Evans P, Porter JB, Sweeters N, Price J, Manji A, Killilea D, Lal A, Vichinsky E. Innate Immune Cell Expression of Pattern Recognition Receptors from Transfused Thalassemia Major Patients During Intensive Combination Chelation Therapy. International BioIron Society Meeting. University College London; April 14-18, 2013.
  • Walter PB, Higa A, Ng V, Weyhmiller MG, Slater NR, Evans P, Porter JB, Sweeters N, Price J, Manji A, Killilea D, Lal A, Vichinsky E. Association Of Cardiac Iron By T2* With Innate Immune Markers In Transfusion-Dependent Thalassemia Patients Undergoing Combined Chelation Therapy. 55th Annual Meeting of the American Society of Hematology. New Orleans, LA; Dec 7-10, 2013. Blood 122(21); 3450. http://bloodjournal.hematologylibrary.org/content/122/21/3450.abstract
  • Walter PB, Pakbaz Z, Nemeth E, Ganz T, Porter JB, Evans P, Houston KM, Fischer R, Weyhmiller MG, Herz M, Miller JL, Hagar R, Neumayr LD, Vichinsky E, Harmatz P. Determinants Of Tissue Iron Loading In Transfused and Non-Transfused ?-Thalassemia and Sickle Cell Disease Patients – Biomarkers Of Iron Regulation and Inflammation. 55th Annual Meeting of the American Society of Hematology. New Orleans, LA; Dec 7-10, 2013. Blood 122(21); 1017. http://bloodjournal.hematologylibrary.org/content/122/21/1017.abstract
  • Walters MC, Sandmaier BM, Storb R, D. Flowers ME, Deeg HJ, O'Donnell P, Woolfrey AE, Kiem H-P. Modulated Cyclophosphamide-Based In Vivo T-Cell Depletion Promotes Engraftment With Minimal Gvhd and Low Toxicity In Fanconi Anemia Patients. 55th Annual Meeting of the American Society of Hematology. New Orleans, LA; Dec 7-10, 2013. Blood 122(21); 4561. http://bloodjournal.hematologylibrary.org/content/122/21/4561.abstract
  • Wang J, Suh JH, Killelea D, Ivani K, Oliveros O, Yuan Q, Vichinsky E, Smith J. Abnormal Reproductive Measures and Seminal Plasma Findings in Men With Thalassemia Major (TM) and Iron Overload. 55th Annual Meeting of the American Society of Hematology. New Orleans, LA; Dec 7-10, 2013. Blood 122(21); 4707. http://bloodjournal.hematologylibrary.org/content/122/21/4707.abstract
  • Wang Z, Diaw L, Dizon M, Barr M, Quinn M, Diggs D, Allen D, Seamon C, Oguhebe A, Darbari D, Zhang Y, Gladwin MT, Hutchinson AA, Burdette L, Hoppe C. Admixture In Sickle Cell Disease Defined By Genome Wide Ancestry Informative Markers Varies By Geographic Region In The United States. 55th Annual Meeting of the American Society of Hematology. New Orleans, LA; Dec 7-10, 2013. Blood 122(21); 995. http://bloodjournal.hematologylibrary.org/content/122/21/995.abstract
  • Wang ZJ, Wood JC, Walter PB, Schoennagel BP, Evans P, Neumayr LD, Weyhmiller MG, Harmatz P, Moon JC, Yuan Q, Miller JL, Weiss G, Grosse R, Meerpohl J, Nielsen P, Vichinsky E, Porter JB, Fischer R. Iron distribution assessed by MRI in sickle cell disease, thalassemia and Diamond Blackfan Anemia (MCSIO Pilot Study). International BioIron Society Meeting. University College London; April 14-18, 2013.
  • Weisdorf DJ, Guethlein LA, Klein JP, Wang T, Marsh SGE, Spellman S, Haagenson MD, Saeturn K, Ladner M, Trachtenberg E, Parham P, Miller JS. Recipient HLA-C1 Enhances The Clinical Advantage Of Killer-Cell Immunoglobulin-Like Receptor B haplotype Donors In Myeloablative Unrelated Transplantation For Acute Myelogenous Leukemia. Blood. 122(21); 549. http://bloodjournal.hematologylibrary.org/content/122/21/549.abstract
  • Weyhmiller MG, Lal A, Fung EB. In-Accuracy Of Bone Density Measurements By DXA In Patients With Hemoglobinopathies and Iron Overload. Blood. New Orleans, LA; Dec 7-10, 2013. Blood 122(21); 966. http://bloodjournal.hematologylibrary.org/content/122/21/966.abstract
  • Yang E, Baltz B, Adams-Graves P, Paley C, Esposito B, Vichinsky EP. 12-month follow-up for patients with sickle cell disease in an ongoing 3-year prospective, non-interventional registry trial. SCDAA 41st Annual Convention; Sept 25-27, 2013. Baltimore, MD.
  • Yesim A, Galanello R, Viprakasit V, Piga A, Harmatz P, Forni GL, Shah F, Grace R, Porter J, Vichinsky E, Wood J, Krishnan S, Zhang P, Abi-Saab W, Rienhoff HY, Neufeld E. The safety, tolerability and efficacy of FBS0701, an iron chelator in clinical development for transfusional iron overload: Data from 72 weeks of treatment. 18th Congress of the European Hematology Association. Stockholm, Sweden; June 13-16, 2013.

Invited Lectures:

  • Hastings C. Clinical experience with cyclodextrin INDs in NPC. NNPDF; Aug 8, 2013 Baltimore, MD.
  • Lal A. Beta Thalassemia Major. Glan-Sagar Institute of Medical Sciences Grand Rounds; Sept 24, 2013, Chandigarh, India.
  • Lal A. Thalassemia: Genetic Diversity and Current Management Strategies. Postgraduate Institute of Medical Education and Research Invited Lecture in Department of Hematology; Sept 20, 2013, Chandigarh, India.
  • Lal A. Non-Transfusion-Dependent Thalassemia. Cooley's Anemia Foundation Patient Conference; June 28, 2013, Philadelphia, PA.
  • Lal A. Thalassemia Intermedia. UC Davis, Dept of Pediatrics, Grand Rounds; Feb 3, 2014, Davis, CA.
  • Treadwell MJ. Emerging Services for Haemoglobinopathies: Teaching the Community about Program Evaluation. 7th Annual Sickle Cell and Thalassemia Advanced Conference; Oct 3-5, 2013; King's Health Partners Academic Health Sciences Centre for London, London, UK.
  • Treadwell MJ. Issues in the Successful Transition from Pediatric to Adult Care in Sickle Cell Disease. Annual Sickle Cell Symposium; Sept 2013; Loma Linda University, Loma Linda, CA.
  • Treadwell MJ. Psychobiological reactivity in sickle cell disease. Jan 2013; ; Southern California Clinical Translational Science Institute, University of Southern California, Los Angeles, CA.
  • Treadwell MJ, Anie K, Asafo M, Creary M, Dennis-Atwi J, Grant A, Lamptey M, Ojodu J, Otaigbe A, Yusuf C, Ohene-Frempong K. Using qualitative and quantitative strategies to inform development of a sickle cell counselor training and certification program. 7th Annual Sickle Cell and Thalassemia Advanced Conference; Oct 3-5, 2013; ; King's Health Partners Academic Health Sciences Centre for London, London, UK.
  • Vichinsky E. Cerebrovascular Disease in Adults with Sickle Cell Disease. 7th Sickle Cell in Focus Conference; June 2013; London, UK.
  • Vichinsky E. Clarice Reid, MD Lecture: The Future of Sickle Cell Disease Research. SCDAA 41st Annual Convention; Sept 25-27, 2013; Baltimore, MD.
  • Vichinsky E. Sickle Cell and Thalassemia. 2013 Highlights of ASH in Latin America; April 2013; Santiago, Chile.

Presentations:

  • Fung EB. Video WebCast for "Think Zinc" Study: Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial. American Journal of Clinical Nutrition, November 2013, http://www.scivee.tv/node/61490.
  • Hagar W. Pain Management in Sickle Cell Disease: Acute and Chronic. Advanced Workshop on Sickle Cell Disease; Nov 14-15, 2013; Children's Hospital & Research Center Oakland, Oakland, CA.
  • Hoppe C. Emerging Therapies and Clinical Trials of Sickle Cell Disease and Vasculopathy. Advanced Workshop on Sickle Cell Disease; Nov 14-15, 2013; Children's Hospital & Research Center Oakland, Oakland, CA.
  • Kelly S. Alloimmunization in Sickle Cell Disease. Advanced Workshop on Sickle Cell Disease; Nov 14-15, 2013; Children's Hospital & Research Center Oakland, Oakland, CA.
  • Lal A. Combined Chelation Therapy. Bayer Hemoglobinopathy Meeting; Feb. 13, 2013, San Francisco, CA.
  • Lal A. Iron Chelation Therapy. Patient Conference; Feb. 10, 2014; Children's Hospital & Research Center Oakland, Oakland, CA.
  • Lal A. Approaches to Chelation. Advanced Workshop on Sickle Cell Disease; Nov 14-15, 2013; Children's Hospital & Research Center Oakland, Oakland, CA.
  • Marsh A. Hemoglobin F Modulation: Hydroxyurea In 2013. Advanced Workshop on Sickle Cell Disease; Nov 14-15, 2013; Children's Hospital & Research Center Oakland, Oakland, CA.
  • Morris CR. Arginine, Glutamine, Nitric Oxide, and Antioxidant Therapy. Advanced Workshop on Sickle Cell Disease; Nov 14-15, 2013; Children's Hospital & Research Center Oakland, Oakland, CA.
  • Morris CR. Pulmonary Hypertension in Sickle Cell Disease. Advanced Workshop on Sickle Cell Disease; Nov 14-15, 2013; Children's Hospital & Research Center Oakland, Oakland, CA.
  • Quirolo KC. Overview of Transfusion Therapy in Sickle Cell Disease. Advanced Workshop on Sickle Cell Disease; Nov 14-15, 2013; Children's Hospital & Research Center Oakland, Oakland, CA.
  • Treadwell M. Clinical Dilemmas and their Solutions. Advanced Workshop on Sickle Cell Disease; Nov 14-15, 2013; Children's Hospital & Research Center Oakland, Oakland, CA.
  • Treadwell M. Issues in Transition from Pediatric to Adult Care in Sickle Cell Disease. Advanced Workshop on Sickle Cell Disease; Nov 14-15, 2013; Children's Hospital & Research Center Oakland, Oakland, CA.
  • Vichinsky E. Role of Transfusion Therapy for Complications Beyond Neurological Complications & the Management of Intermittently-Transfused Patients. Advanced Workshop on Sickle Cell Disease; Nov 14-15, 2013; Children's Hospital & Research Center Oakland, Oakland, CA.
  • Walters MC. Alternate Donor Hematopoietic Cell Transplantation for Sickle Cell Disease. Advanced Workshop on Sickle Cell Disease; Nov 14-15, 2013; Children's Hospital & Research Center Oakland, Oakland, CA.
  • Walters MC. Gene Therapy and Hemoglobinopathies. Advanced Workshop on Sickle Cell Disease; Nov 14-15, 2013; Children's Hospital & Research Center Oakland, Oakland, CA.

Profiles:

updated 4 April 2014


Children's Hospital & Research Center Oakland • 747 52nd Street, Oakland, California 94609 • Phone: (510) 428-3000